When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

Zentara, a groundbreaking new company, is pushing to steer the conversation away from these ineffective tactics to ...

In the February 10 Nature Medicine, scientists led by Jorge Llibre-Guerra and Randall Bateman at Washington University, St.

The trial data indicate a temporal disconnection between volume changes (which continue to progress beyond 12 months) and reductions in amyloid-PET (most notable within 6 months), and a spatial ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

Nuclear cardiology is a specialised field in nuclear medicine that evaluates the heart function to help diagnosing conditions ...

Attribution (BY): Credit must be given to the creator. Amyloid formation is involved in widespread health conditions such as Alzheimer’s disease, Parkinson’s disease, and type-2 diabetes. Amyloid ...

New research suggests that a specific type of body fat, called visceral fat, may play a key role in the early buildup of ...

LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...